Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology
Odabas, Hatice, Ulas, Arife, Aydin, Kubra, Inanc, Mevlude, Aksoy, Asude, Yazilitas, Dogan, Turkeli, Mehmet, Yuksel, Sinemis, Inal, Ali, Ekinci, Ahmet S., Sevinc, Alper, Demirci, Nebi S., Uysal, MukremVolume:
36
Language:
english
Journal:
Tumor Biology
DOI:
10.1007/s13277-015-3728-0
Date:
December, 2015
File:
PDF, 632 KB
english, 2015